HTA & Market Access

30 Items

Section Editor

Roberto Ravasio 
Pharmes, Head of Health Economics Research | Milan, Italy

 

All Items

  • Getting your devices ready for MDR compliance – a clinical approach and orthopaedic device manufacturers’ perspective

    Peter Fennema, Hassan Achakri
    70-75
    DOI: https://doi.org/10.33393/abtpn.2019.294
  • Lean Management: organizational innovations in hematological Day-Hospitals Lean Management: innovazioni organizzative nei Day Hospital Ematologici

    Caterina Bianciardi, Jacopo Guercini
    62-69
    DOI: https://doi.org/10.33393/abtpn.2019.290
  • Performance indicators for monitoring the integrated care pathway of patients with colorectal cancer: the E.Pic.A. project Performance indicators for colorectal cancer

    Andrea Ricotti, Giovanni Messori Ioli, Mattia Altini, Letizia Bachini, William Balzi, Giovanni Luca Frassineti, Fabrizio Gemmi, Ilaria Massa, Andrea Pierini, Oscar Bertetto, Patrizia Racca
    48-54
    DOI: https://doi.org/10.33393/abtpn.2019.292
  • Key performance indicators for monitoring the integrated care pathway in breast cancer: the E.Pic.A. project

    Mattia Altini, William Balzi, Roberta Maltoni, Fabio Falcini, Flavia Foca, Giovanni Messori Ioli, Andrea Ricotti, Oscar Bertetto, Marinella Mistrangelo, Gianni Amunni, Fabrizio Gemmi, Letizia Bachini, Andrea Silenzi, Roberta Pastorino, Andrea Barbara, Andrea Pierini, Ilaria Massa
    31-38
    DOI: https://doi.org/10.33393/abtpn.2019.291
  • A Budget impact analysis of adalimumab biosimilar: the Italian context Analisi di budget impact del biosimilare di adalimumab: lo scenario italiano

    Roberto Ravasio, Silvio Mazzi, Maria Esposito, Gionata Fiorino, Alberto Migliore
    16-23
    DOI: https://doi.org/10.33393/abtpn.2019.280
26-50 of 30